Moreover, the metformin/nelfinavir combination is significantly more effective in increasing the expression of p53 and p21 in cervical cancer cell lines and tumor tissues than either metformin alone or nelfinavir alone. This evidence concerns the gene TP53 and cervical carcinoma.